查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403412

到 2030 年痤瘡治療市場預測：按產品、痤瘡類型、藥物類型、治療方法、給藥途徑、最終用戶和地區進行的全球分析

Acne Treatment Market Forecasts to 2030 - Global Analysis By Product (Isotretinoi, Antibiotics, Retinoids and Other Products), Acne Type, Drug Type, Treatment, Route of Administration, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球痤瘡治療市場規模為 111 億美元，預計在預測期內將以 7.1% 的複合年成長率成長，並在 2030 年達到 180 億美元。

皮膚毛孔和開口（包括毛囊）堵塞是痤瘡（一種與皮膚相關的疾病）的原因。青少年和成年早期的人是表現出這種位置的主要人群。這是一種非常常見的皮膚病，影響所有皮膚類型，無論年齡如何。抗生素和類視色素A用於治療此類皮膚病。儘管缺乏證據表明治療這些皮膚狀況會產生預期的效果，但由於其美容價值，該行業長期以來一直主導著該領域。

根據美國國家生物技術資訊中心 (NCBI) 的數據，到 2022 年，痤瘡的盛行率將影響全球 9.4% 的人口。它是世界上第八常見的疾病。

促進生長的因素：痤瘡盛行率增加

皮膚病影響很多人。隨著眾多用於治療的產品（例如類類視色素A、類視色素A以及口服和局部抗生素）的出現，全球大眾對痤瘡產品和現成的治療方法選擇的認知越來越強。因此，提高患者意識預計將推動市場擴張。有效的產品行銷激發目標受眾的興趣也是促進市場拓展的關鍵因素。

成長抑制因素：對產品安全的擔憂

根據給藥和給藥方法，痤瘡治療藥物可能會產生各種副作用。皮膚發炎和乾燥是局部性痤瘡治療最常見的副作用。內服藥物可能有更嚴重的副作用。抗生素會引起噁心、嘔吐、頭暈和輕微頭痛。圍繞痤瘡治療藥物的安全性擔憂預計​​將阻礙市場擴張。

機會：提高認知

對微創美容療程的需求不斷成長。皮膚科醫生更喜歡透過局部治療和微創手術而不是手術治療來治療皮膚病。由於更好的決策、改善的患者與醫生的聯繫以及詳細記錄的程序，對臉部和皮膚相關問題的治療需求正在增加。這鼓勵了使用較少疼痛的美容組合治療方法。

威脅：治療費用高

有效的痤瘡治療有時可能很昂貴，特別是當涉及處方藥和雷射治療等手術時。對於財力有限或沒有保險的人來說，這是一個嚴重的缺點。痤瘡治療可能不是一次性費用。有些治療方法需要定期維護和追蹤預約，這會增加整體成本。這些因素阻礙了市場的成長。

COVID-19 的影響

由於全球尋求治療的人數減少，痤瘡治療藥物的成長速度因疫情而放緩。由於COVID-19的影響，該行業的主要公司收入大幅下降。藥品銷售也受到生產減少、醫療支出重新分配、供應鏈中斷、皮膚科診所關閉和其他問題的影響。與長期使用醫用口罩相關的痤瘡爆發增加進一步增加了對藥品的需求。

預計治療設備領域在預測期內將是最大的。

預計治療設備領域在預測期內將是最大的。痤瘡治療設備的開發正在推動該行業的擴張。雷射治療痤瘡疤痕的目的是減少以前痤瘡發作留下的疤痕。塗抹在皮膚真皮層的持續光療會破壞疤痕組織並促進新的健康皮膚細胞的生長以取代受損的組織。

預計類類視色素A產業在預測期內複合年成長率最高

預計類類視色素A細分市場在預測期內複合年成長率最高。類視色素A現在被廣泛用於去除毛孔中多餘的皮脂和灰塵。這種方法被認為是安全的，幾乎沒有副作用，使其成為一個很大的市場領域。它的作用是阻止死皮細胞堵塞毛孔，這是痤瘡的主要原因。透過促進細胞更新，類視色素A的產生可以防止毛孔堵塞。

比最大的地區

由於該地區痤瘡患者數量不斷增加以及與美容相關的消費者擔憂不斷增加，預計北美將在預測期內佔據最大的市場佔有率。由於該地區主要企業推出新產品以及患者人數顯著增加，該市場將成長。隨著創新治療方法和解決方案的使用越來越頻繁，市場佔有率可能會擴大到更高的數量。

複合年成長率最高的地區

由於市場參與企業數量不斷增加以及公眾對多種藥物的認知不斷增強，預計亞太地區在預測期內將保持最高的複合年成長率。該地區擁有最大的各種旨在實現美麗肌膚的化妝品的基本客群。由於氣候原因，色素沉著也被認為是該地區的重要議題。此外，預測期內消費藥品使用量的增加將推動成長。

免費客製化服務

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 公司之間的競爭關係

第5章全球痤瘡治療市場：依產品

  • 類視色素
  • 抗生素
  • 類視色素A
  • 其他產品

第6章全球痤瘡治療市場：按痤瘡類型

  • 適度
  • 溫和的
  • 中度至重度

第7章全球痤瘡治療市場：依藥物類型

  • 處方箋
  • 店面銷售(OTC)

第8章全球痤瘡治療市場：依治療方法

  • 裝置
    • 高頻裝置
    • 雷射裝置
  • 治療性治療
    • 發炎藥
    • 化學換膚
    • 荷爾蒙藥物
    • 類視色素A療法
    • 抗生素
  • 其他治療方法

第9章全球痤瘡治療市場：依給藥途徑

  • 口服
  • 可注射的
  • 局部的

第10章全球痤瘡治療市場：依最終用戶分類

  • 醫療水療中心
  • 皮膚科診所
  • 醫院
  • 其他最終用戶

第11章全球痤瘡治療市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第12章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司簡介

  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Leo Pharma A/S
  • Stiefel Laboratories, Inc.
  • Bayer AG
  • Roche Holding AG
  • Bausch Health Companies Inc.
  • Galderma Laboratories
  • Hoffman La Roche Ltd
  • Pfizer Inc.
  • Valeant Pharmaceutical International, Inc.
  • GlaxoSmithKline Plc.
  • Cutera Inc.
  • Vyne Therapeutics Inc.
  • Botanix Pharmaceuticals
  • ABBVIE INC.
  • Candela Corporation
  • Almirall, SA
Product Code: SMRC24637

According to Stratistics MRC, the Global Acne Treatment Market is accounted for $11.1 billion in 2023 and is expected to reach $18.0 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Clogged skin pores and openings, including hair follicles, are the cause of acne, a skin-related condition. Teenagers and those in their early adult years are the key demographics that exhibit this arrangement. This is an extremely prevalent skin condition that affects all skin types regardless of age. Antibiotics and retinoids are used in the treatment of this type of skin condition. Even though there is no certainty that treating these skin conditions would provide the desired effects, the industry has long dominated this field due to its cosmetic value.

According to the National Center for Biotechnology Information (NCBI), the prevalence of acne affected 9.4% of the global population in 2022. It is the eighth most prevalent disease in the world.

Market Dynamics:

Driver:

Increasing prevalence of acne

Skin disorders affect a large percentage of people. The worldwide public is becoming more aware of acne products and accessible treatment choices due to the advent of numerous products used for the treatment, such as retinoids, isotretinoids, and oral and topical antibiotics. Therefore, it is anticipated that rising patient awareness would promote market expansion. Effective product marketing to pique the interest of the intended audience is also a key component in driving market expansion.

Restraint:

Concerns about product safety

Treatments for acne might have different side effects according on the dosage and mode of administration. Skin irritation and dryness are the most frequent adverse effects of topical acne medications. More severe adverse effects are possible with oral medicines. Antibiotics may cause nausea or vomiting, as well as dizziness and light headedness. It is anticipated that the safety concerns surrounding acne treatment solutions would impede market expansion.

Opportunity:

Increasing awareness

The demand for minimally invasive cosmetic treatment treatments is increasing. Dermatologists would rather use topical treatments or less invasive techniques to address skin conditions than surgical ones. The need for treatments connected to face and skin-related issues is rising as a result of better decision-making, improved patient-physician connections, and well-documented procedures. This has prompted the use of less painful cosmetic combination treatment methods.

Threat:

High cost of treatment

Effective acne treatments can occasionally be costly, particularly when it comes to prescription drugs or procedures like laser therapy. This is a serious drawback for people with little resources or no insurance. Treatments for acne might not be a one-time expense. The overall cost of some procedures is increased by the need for regular maintenance or follow-up appointments. These factors are hampering the growth of the market.

COVID-19 Impact:

The epidemic slowed the rise of acne medications since fewer people worldwide were seeking treatment. Leading companies in the industry experienced significant revenue losses as a result of COVID-19. Drug sales were also impacted by reduced manufacturing, redistributing healthcare spending, broken supply chains, shutting dermatological clinics, and other issues. The rise in acne occurrences linked to extended usage of medical face masks further contributed to the demand for pharmaceuticals.

The therapeutic devices segment is expected to be the largest during the forecast period

The therapeutic devices segment is expected to be the largest during the forecast period. The development of therapeutic gadgets for the treatment of acne is propelling this industry's expansion. Reducing the visibility of scars from previous acne episodes is the goal of laser therapy for acne scars. Continuous light therapy is applied to the skin's dermis layer to break up scar tissue and promote the growth of new, healthy skin cells to replace the damaged tissue.

The retinoid segment is expected to have the highest CAGR during the forecast period

The retinoid segment is expected to have the highest CAGR during the forecast period. Retinoids are now widely used by people to clear their skin of excess oil and dust that has clogged their open pores. The method is a large market sector since it is regarded as safe and has little negative effects. They function by stopping the main cause of acne, dead skin cells, from obstructing pores. By encouraging cell turnover, retinoid production keeps the pores from becoming clogged.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the region's increasing majority of acne and growing consumer problems related to beauty. The market will grow as a result of the introduction of new products by significant regional companies and a notable increase in the patient population. The market share will increase to a bigger volume as innovative treatments and solutions are used more frequently.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to rising awareness among the population about several drugs combined with the increasing number of companies entering the market. The greatest customer base for a variety of cosmetic goods created to achieve clean skin is found in this region. Due to the climate, hyperpigmentation has also been identified as a significant issue in this area. Moreover, growth would be fueled by consumers' increasing medicine usage over the projection period.

Key players in the market:

Some of the key players in Acne Treatment market include Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Leo Pharma A/S, Stiefel Laboratories, Inc., Bayer AG, Roche Holding AG, Bausch Health Companies Inc., Galderma Laboratories, Hoffman La Roche Ltd, Pfizer Inc., Valeant Pharmaceutical International, Inc., GlaxoSmithKline Plc., Cutera Inc., Vyne Therapeutics Inc., Botanix Pharmaceuticals, ABBVIE INC., Candela Corporation and Almirall, S.A.

Key Developments:

In July 2022, Glenmark Pharmaceuticals launched a new acne drug, MINYM gel, in India. This is India's first topical Minocycline 4% Gel to treat acne.

In March 2022, Galderma introduced its breakthrough skincare cream, Twyneo to treat moderate to severe facial acne, to the U.S. market at the American Academy of Dermatology (AAD) Annual Meeting.

In January 2022, GALDERMA announced to receive its antitrust clearance from the U.S. authorities after completing the acquisition of ALASTIN Skincare, Inc. for developing innovative and clinically-tested physician-dispensed skincare products.

Products Covered:

  • Isotretinoi
  • Antibiotics
  • Retinoids
  • Other Products

Acne Types Covered:

  • Moderate
  • Mild
  • Moderate to Severe

Drug Types Covered:

  • Prescription
  • Over the Counter (OTC)

Treatments Covered:

  • Devices
  • Therapeutic Treatment
  • Other Treatments

Route of Administrations Covered:

  • Oral
  • Injectable
  • Topical

End Users Covered:

  • MedSpa
  • Dermatology Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Acne Treatment Market, By Product

  • 5.1 Introduction
  • 5.2 Isotretinoi
  • 5.3 Antibiotics
  • 5.4 Retinoids
  • 5.5 Other Products

6 Global Acne Treatment Market, By Acne Type

  • 6.1 Introduction
  • 6.2 Moderate
  • 6.3 Mild
  • 6.4 Moderate to Severe

7 Global Acne Treatment Market, By Drug Type

  • 7.1 Introduction
  • 7.2 Prescription
  • 7.3 Over the Counter (OTC)

8 Global Acne Treatment Market, By Treatment

  • 8.1 Introduction
  • 8.2 Devices
    • 8.2.1 Radio frequency Devices
    • 8.2.2 Laser Devices
  • 8.3 Therapeutic Treatment
    • 8.3.1 Anti-inflammatory Drugs
    • 8.3.2 Chemical Peels
    • 8.3.3 Hormonal Drugs
    • 8.3.4 Retinoid Therapy
    • 8.3.8 Antibiotics
  • 8.4 Other Treatments

9 Global Acne Treatment Market, By Route of Administration

  • 9.1 Introduction
  • 9.2 Oral
  • 9.3 Injectable
  • 9.4 Topical

10 Global Acne Treatment Market, By End User

  • 10.1 Introduction
  • 10.2 MedSpa
  • 10.3 Dermatology Clinics
  • 10.4 Hospitals
  • 10.5 Other End Users

11 Global Acne Treatment Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Johnson & Johnson Services, Inc.
  • 13.2 Teva Pharmaceutical Industries Ltd.
  • 13.3 Leo Pharma A/S
  • 13.4 Stiefel Laboratories, Inc.
  • 13.5 Bayer AG
  • 13.6 Roche Holding AG
  • 13.7 Bausch Health Companies Inc.
  • 13.8 Galderma Laboratories
  • 13.9 Hoffman La Roche Ltd
  • 13.10 Pfizer Inc.
  • 13.11 Valeant Pharmaceutical International, Inc.
  • 13.12 GlaxoSmithKline Plc.
  • 13.13 Cutera Inc.
  • 13.14 Vyne Therapeutics Inc.
  • 13.15 Botanix Pharmaceuticals
  • 13.16 ABBVIE INC.
  • 13.17 Candela Corporation
  • 13.18 Almirall, S.A.

List of Tables

  • Table 1 Global Acne Treatment Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Acne Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Acne Treatment Market Outlook, By Isotretinoi (2021-2030) ($MN)
  • Table 4 Global Acne Treatment Market Outlook, By Antibiotics (2021-2030) ($MN)
  • Table 5 Global Acne Treatment Market Outlook, By Retinoids (2021-2030) ($MN)
  • Table 6 Global Acne Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 7 Global Acne Treatment Market Outlook, By Acne Type (2021-2030) ($MN)
  • Table 8 Global Acne Treatment Market Outlook, By Moderate (2021-2030) ($MN)
  • Table 9 Global Acne Treatment Market Outlook, By Mild (2021-2030) ($MN)
  • Table 10 Global Acne Treatment Market Outlook, By Moderate to Severe (2021-2030) ($MN)
  • Table 11 Global Acne Treatment Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 12 Global Acne Treatment Market Outlook, By Prescription (2021-2030) ($MN)
  • Table 13 Global Acne Treatment Market Outlook, By Over the Counter (OTC) (2021-2030) ($MN)
  • Table 14 Global Acne Treatment Market Outlook, By Treatment (2021-2030) ($MN)
  • Table 15 Global Acne Treatment Market Outlook, By Devices (2021-2030) ($MN)
  • Table 16 Global Acne Treatment Market Outlook, By Radio frequency Devices (2021-2030) ($MN)
  • Table 17 Global Acne Treatment Market Outlook, By Laser Devices (2021-2030) ($MN)
  • Table 18 Global Acne Treatment Market Outlook, By Therapeutic Treatment (2021-2030) ($MN)
  • Table 19 Global Acne Treatment Market Outlook, By Anti-inflammatory Drugs (2021-2030) ($MN)
  • Table 20 Global Acne Treatment Market Outlook, By Chemical Peels (2021-2030) ($MN)
  • Table 21 Global Acne Treatment Market Outlook, By Hormonal Drugs (2021-2030) ($MN)
  • Table 22 Global Acne Treatment Market Outlook, By Retinoid Therapy (2021-2030) ($MN)
  • Table 23 Global Acne Treatment Market Outlook, By Antibiotics (2021-2030) ($MN)
  • Table 24 Global Acne Treatment Market Outlook, By Other Treatments (2021-2030) ($MN)
  • Table 25 Global Acne Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 26 Global Acne Treatment Market Outlook, By Oral (2021-2030) ($MN)
  • Table 27 Global Acne Treatment Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 28 Global Acne Treatment Market Outlook, By Topical (2021-2030) ($MN)
  • Table 29 Global Acne Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Acne Treatment Market Outlook, By MedSpa (2021-2030) ($MN)
  • Table 31 Global Acne Treatment Market Outlook, By Dermatology Clinics (2021-2030) ($MN)
  • Table 32 Global Acne Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 33 Global Acne Treatment Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

11 Global Acne Treatment Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies